POLYMER BASED DRUG DELIVERY FORMULATIONS

Brand Owner (click to sort) Address Description
ALKERMES Alkermes, Inc. 852 Winter Street Waltham MA 024511420 polymer-based drug delivery formulations for clinical use;
MEDISORB ALKERMES PHARMA IRELAND LIMITED Connaught House 1, Burlington Road Dublin 4 Ireland polymer-based drug delivery formulations for clinical use;
PROLEASE Alkermes, Inc. 852 Winter Street Waltham MA 024511420 polymer-based drug delivery formulations for clinical use;PRO LEASE;
THE SCIENCE OF ALCOHOL ADDICTION Alkermes, Inc. 852 Winter Street Waltham MA 024511420 Polymer-Based Drug Delivery Formulations for Clinical Use; and Pharmaceutical Products, Namely, Injectable Drug Delivery Formulations Used as Facilitating Agents for Other Pharmaceutical Preparations;
VIVITREX CEPHALON, INC. 145 Brandywine Parkway West Chester PA 19380 Polymer-based Drug Delivery Formulations for Clinical Use; and Pharmaceutical Products, namely, Injectable Drug Delivery Formulations used as Facilitating Agents for other Pharmaceutical Preparations;
VIVITROL Alkermes, Inc. 852 Winter Street Waltham MA 024511420 Polymer-based Drug Delivery Formulations for Clinical Use; and Pharmaceutical Products, namely, Injectable Drug Delivery Formulations used as Facilitating Agents for other Pharmaceutical Preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A drug delivery system incorporated into a cardiac device for delivering a dose of a drug to a patient upon detection of a particular medical condition. The cardiac device may be, for example, an implantable cardioverter/defibrillator, cardiac pacemaker, or combination device that communicates via a radio frequency link with a drug delivery device. The drug delivery device is preferably an electrically modulated transdermal drug delivery device for delivering the drug transdermally in accordance with a signal received from the cardiac device.